I
164.85
1.27 (0.78%)
| Penutupan Terdahulu | 163.58 |
| Jumlah Dagangan | 795,909 |
| Harga / Pendapatan (P/E Ke hadapan) | 14.37 |
| Harga / Jualan (P/S) | 1.49 |
| Harga / Buku (P/B) | 1.31 |
| Julat 52 Minggu |
| Margin Keuntungan | 9.82% |
| Margin Operasi (TTM) | 12.83% |
| EPS Cair (TTM) | 9.71 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -4.80% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 24.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 37.12% |
| Nisbah Semasa (MRQ) | 1.29 |
| Aliran Tunai Operasi (OCF TTM) | 1.16 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 901.28 M |
| Pulangan Atas Aset (ROA TTM) | 4.35% |
| Pulangan Atas Ekuiti (ROE TTM) | 8.30% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | ICON plc | Bercampur | Menurun |
AISkor Stockmoo
0.3
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.29 |
|
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Mid Value |
| % Dimiliki oleh Orang Dalam | 0.63% |
| % Dimiliki oleh Institusi | 92.70% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Brave Warrior Advisors, Llc | 30 Jun 2026 | 3,153,308 |
| Trinity Street Asset Management Llp | 30 Jun 2026 | 1,535,462 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |